BIOVENTUS INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BIOVENTUS INC. stock issued during period, value, new issues for the quarter ending 2026-06-27 was $853.00K, a 35.23% decline year-over-year.
- BIOVENTUS INC. stock issued during period, value, new issues for the quarter ending 2026-03-28 was $120.00K, a 20.00% decline year-over-year.
- BIOVENTUS INC. stock issued during period, value, new issues for the quarter ending 2025-12-31 was $511.00K, a 53.67% decline year-over-year.
- BIOVENTUS INC. stock issued during period, value, new issues for the quarter ending 2025-09-27 was $96.00K, a 82.64% decline year-over-year.
- BIOVENTUS INC. stock issued during period, value, new issues for fiscal 2025 was $2.07M, a 15.07% decline from fiscal 2024.
- BIOVENTUS INC. stock issued during period, value, new issues for fiscal 2024 was $2.44M, a 213.88% increase from fiscal 2023.
- BIOVENTUS INC. stock issued during period, value, new issues for fiscal 2023 was $778.00K, a 86.64% decline from fiscal 2022.
- BIOVENTUS INC. stock issued during period, value, new issues for fiscal 2022 was $5.82M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-27 | $853.00K 10-Q · filed 2026-08-05 | $1.58M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-28 | $120.00K 10-Q · filed 2026-05-06 | $2.04M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $511.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $2.07M 10-K · filed 2026-03-05 |
| 2025-09-27 | $96.00K 10-Q · filed 2025-11-04 | $2.67M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-28 | $1.32M 10-Q · filed 2026-08-05 | $3.12M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-29 | $150.00K 10-Q · filed 2026-05-06 | $2.30M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $2.44M 10-K · filed 2026-03-05 |
| 2024-09-28 | $553.00K 10-Q · filed 2025-11-04 | $1.50M derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-06-29 | $496.00K 10-Q · filed 2025-08-06 | $1.34M derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-03-30 | $290.00K 10-Q · filed 2025-05-06 | $984.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2023-12-31 | $158.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $778.00K 10-K · filed 2026-03-05 |
| 2023-09-30 | $397.00K 10-Q · filed 2024-11-05 | $1.70M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-07-01 | $139.00K 10-Q · filed 2024-08-06 | $1.79M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-04-01 | $84.00K 10-Q · filed 2024-05-07 | $3.83M derived: sum of 4 quarters · filed 2025-03-11 |
| 2022-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $5.82M 10-K · filed 2025-03-11 |
| 2022-10-01 | $482.00K 10-Q · filed 2023-11-07 | |
| 2022-07-02 | $2.18M 10-Q · filed 2023-08-08 | |
| 2022-04-02 | $2.08M 10-Q · filed 2023-05-16 | |
| 2021-10-02 | $417.00K 10-Q · filed 2022-11-21 | |
| 2021-07-03 | $314.00K 10-Q · filed 2022-08-12 | |
| 2021-04-03 | $106.45M 10-Q · filed 2021-05-13 |